JDD in the News: Efficacy and Tolerability of Stabilized, Bioactive Retinol – JDDonline – Journal of Drugs in Dermatology
Healio featured a JDD study on the use of tildrakizumab for plaque psoriasis. Jayme Heim, MSN, FNP-BC, and colleagues wrote…
Healio featured a JDD study on the use of tildrakizumab for plaque psoriasis. Jayme Heim, MSN, FNP-BC, and colleagues wrote…
While 84% of commercials targeted female consumers and 77% utilized celebrity influence, less than half mentioned specific ingredients in skin lightening products.
Prurigo nodularis (PN) is a chronic inflammatory skin disease characterized by intense pruritus and skin nodules. Beyond the skin, PN involves circulating blood inflammation that…
In this interview, Dr Eichenfield outlines key recommendations and updates from the latest guidelines for managing atopic dermatitis with topical medications.
These challenges may exacerbate racial inequities in care access and quality, according to a new study.
The new research will compare eblasakimab to dupilumab and lebrikizumab.
Dermatology Times asked our readers to share what conferences they are looking forward to in the second quarter of 2024.
Responding to JAAD Case Reports articles indicating a growing problem
Chronic kidney disease (CKD) is a non-communicable disease that currently widely affects around 850 million people. Nowadays…
Earn CME credit and learn how to optimize a multimodal treatment approach for hidradenitis suppurativa.
A man with a history of polysubstance use presents with new bullae on his bilateral lower extremities. What is your diagnosis?